Ocugen IncNASDAQ:OCGN
- LAST PRICE1.3900
- TODAY'S CHANGE (%)0.1100 (8.5937%)
- Bid / Lots1.3800/ 3
- Ask / Lots1.4300/ 35
- Open / Previous Close1.2600 / 1.2800
- Day Range
- 52 Week Range
- Volume7,637,305
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCGN |
|---|---|---|
| 09:32 ET | 145248 | 1.3004 |
| 09:34 ET | 84714 | 1.34 |
| 09:36 ET | 194625 | 1.365 |
| 09:38 ET | 67289 | 1.3681 |
| 09:39 ET | 18834 | 1.36 |
| 09:41 ET | 71411 | 1.3695 |
| 09:43 ET | 29366 | 1.35 |
| 09:45 ET | 71570 | 1.3635 |
| 09:48 ET | 79519 | 1.3797 |
| 09:50 ET | 262115 | 1.3999 |
| 09:52 ET | 139125 | 1.409 |
| 09:54 ET | 198032 | 1.4099 |
| 09:56 ET | 158205 | 1.405 |
| 09:57 ET | 50094 | 1.39 |
| 09:59 ET | 23567 | 1.39 |
| 10:01 ET | 60833 | 1.405 |
| 10:03 ET | 51329 | 1.395 |
| 10:06 ET | 191911 | 1.3603 |
| 10:08 ET | 47798 | 1.38 |
| 10:10 ET | 22930 | 1.3716 |
| 10:12 ET | 27092 | 1.3793 |
| 10:14 ET | 15066 | 1.3704 |
| 10:15 ET | 21994 | 1.3795 |
| 10:17 ET | 33088 | 1.3797 |
| 10:19 ET | 65123 | 1.385 |
| 10:21 ET | 7390 | 1.3892 |
| 10:24 ET | 1300 | 1.385 |
| 10:26 ET | 10161 | 1.383 |
| 10:28 ET | 87089 | 1.4 |
| 10:30 ET | 74352 | 1.4101 |
| 10:32 ET | 69141 | 1.4132 |
| 10:33 ET | 22050 | 1.4102 |
| 10:35 ET | 21403 | 1.4101 |
| 10:37 ET | 123611 | 1.418 |
| 10:39 ET | 4313 | 1.4101 |
| 10:42 ET | 58619 | 1.4199 |
| 10:44 ET | 77478 | 1.4 |
| 10:46 ET | 33899 | 1.405 |
| 10:48 ET | 17684 | 1.4 |
| 10:50 ET | 17602 | 1.4 |
| 10:51 ET | 67444 | 1.3993 |
| 10:53 ET | 2727 | 1.395 |
| 10:55 ET | 11905 | 1.3901 |
| 10:57 ET | 7979 | 1.3994 |
| 11:00 ET | 3467 | 1.395 |
| 11:02 ET | 6211 | 1.395 |
| 11:04 ET | 6340 | 1.3994 |
| 11:06 ET | 3436 | 1.395 |
| 11:08 ET | 3450 | 1.3999 |
| 11:09 ET | 725 | 1.395 |
| 11:11 ET | 4248 | 1.395 |
| 11:13 ET | 13331 | 1.395 |
| 11:15 ET | 47915 | 1.3782 |
| 11:18 ET | 8078 | 1.3703 |
| 11:20 ET | 15859 | 1.375 |
| 11:22 ET | 206180 | 1.355 |
| 11:24 ET | 6581 | 1.355 |
| 11:26 ET | 16792 | 1.35 |
| 11:27 ET | 16450 | 1.355 |
| 11:29 ET | 4101 | 1.36 |
| 11:31 ET | 7329 | 1.36 |
| 11:33 ET | 4784 | 1.35 |
| 11:36 ET | 32855 | 1.36 |
| 11:38 ET | 1551 | 1.3589 |
| 11:40 ET | 2035 | 1.3589 |
| 11:42 ET | 5243 | 1.36 |
| 11:44 ET | 37393 | 1.3613 |
| 11:45 ET | 31548 | 1.3603 |
| 11:47 ET | 5850 | 1.365 |
| 11:49 ET | 63147 | 1.37 |
| 11:51 ET | 14019 | 1.37 |
| 11:54 ET | 24507 | 1.3782 |
| 11:56 ET | 29002 | 1.38 |
| 11:58 ET | 34103 | 1.38 |
| 12:00 ET | 8595 | 1.3811 |
| 12:02 ET | 4449 | 1.39 |
| 12:03 ET | 2700 | 1.39 |
| 12:05 ET | 4301 | 1.385 |
| 12:07 ET | 54705 | 1.38 |
| 12:09 ET | 21879 | 1.365 |
| 12:12 ET | 2601 | 1.365 |
| 12:14 ET | 26452 | 1.3599 |
| 12:16 ET | 48529 | 1.355 |
| 12:18 ET | 9812 | 1.355 |
| 12:20 ET | 11536 | 1.36 |
| 12:21 ET | 3203 | 1.3589 |
| 12:23 ET | 1499 | 1.36 |
| 12:25 ET | 2020 | 1.35 |
| 12:27 ET | 2451 | 1.35 |
| 12:30 ET | 1592 | 1.3521 |
| 12:32 ET | 3216 | 1.355 |
| 12:34 ET | 13519 | 1.355 |
| 12:36 ET | 866 | 1.355 |
| 12:38 ET | 10820 | 1.36 |
| 12:39 ET | 29344 | 1.3513 |
| 12:41 ET | 2200 | 1.36 |
| 12:43 ET | 3406 | 1.355 |
| 12:45 ET | 165553 | 1.34 |
| 12:48 ET | 1812 | 1.335 |
| 12:52 ET | 2651 | 1.3381 |
| 12:54 ET | 30246 | 1.325 |
| 12:56 ET | 7417 | 1.3281 |
| 12:57 ET | 37499 | 1.32 |
| 12:59 ET | 49115 | 1.325 |
| 01:01 ET | 10152 | 1.33 |
| 01:03 ET | 6004 | 1.33 |
| 01:06 ET | 244772 | 1.375 |
| 01:08 ET | 216709 | 1.415 |
| 01:10 ET | 254481 | 1.4205 |
| 01:12 ET | 15342 | 1.425 |
| 01:14 ET | 27881 | 1.415 |
| 01:15 ET | 29975 | 1.4135 |
| 01:17 ET | 7559 | 1.41 |
| 01:19 ET | 56668 | 1.43 |
| 01:21 ET | 147336 | 1.4201 |
| 01:24 ET | 7794 | 1.423 |
| 01:26 ET | 9682 | 1.425 |
| 01:28 ET | 17772 | 1.43 |
| 01:30 ET | 16180 | 1.4241 |
| 01:32 ET | 7268 | 1.43 |
| 01:33 ET | 1845 | 1.43 |
| 01:35 ET | 6896 | 1.425 |
| 01:37 ET | 8036 | 1.42 |
| 01:39 ET | 142659 | 1.44 |
| 01:42 ET | 48657 | 1.436 |
| 01:44 ET | 11563 | 1.44 |
| 01:46 ET | 62175 | 1.43 |
| 01:48 ET | 183902 | 1.41 |
| 01:50 ET | 24871 | 1.4011 |
| 01:51 ET | 36143 | 1.414 |
| 01:53 ET | 3507 | 1.415 |
| 01:55 ET | 31657 | 1.405 |
| 01:57 ET | 14860 | 1.406 |
| 02:00 ET | 157534 | 1.405 |
| 02:02 ET | 100 | 1.405 |
| 02:04 ET | 6675 | 1.405 |
| 02:06 ET | 1400 | 1.405 |
| 02:08 ET | 2500 | 1.41 |
| 02:09 ET | 195362 | 1.4 |
| 02:11 ET | 180165 | 1.42 |
| 02:13 ET | 22909 | 1.415 |
| 02:15 ET | 25960 | 1.415 |
| 02:18 ET | 10201 | 1.41 |
| 02:20 ET | 68281 | 1.4293 |
| 02:22 ET | 11098 | 1.4201 |
| 02:24 ET | 64421 | 1.4243 |
| 02:26 ET | 34359 | 1.41 |
| 02:27 ET | 3000 | 1.41 |
| 02:29 ET | 1621 | 1.4101 |
| 02:31 ET | 100 | 1.419 |
| 02:33 ET | 16925 | 1.4099 |
| 02:36 ET | 14017 | 1.405 |
| 02:38 ET | 1529 | 1.404 |
| 02:40 ET | 1627 | 1.4005 |
| 02:42 ET | 22093 | 1.405 |
| 02:44 ET | 15399 | 1.405 |
| 02:45 ET | 4347 | 1.41 |
| 02:47 ET | 3604 | 1.4005 |
| 02:49 ET | 2315 | 1.41 |
| 02:51 ET | 34507 | 1.41 |
| 02:54 ET | 11144 | 1.4115 |
| 02:56 ET | 1771 | 1.4101 |
| 02:58 ET | 6753 | 1.42 |
| 03:00 ET | 4052 | 1.4199 |
| 03:02 ET | 79455 | 1.395 |
| 03:03 ET | 8397 | 1.385 |
| 03:05 ET | 12445 | 1.375 |
| 03:07 ET | 4745 | 1.373 |
| 03:09 ET | 12010 | 1.375 |
| 03:12 ET | 8694 | 1.39 |
| 03:14 ET | 2947 | 1.3814 |
| 03:16 ET | 2859 | 1.39 |
| 03:18 ET | 21709 | 1.383 |
| 03:20 ET | 1555 | 1.3892 |
| 03:21 ET | 2676 | 1.38 |
| 03:23 ET | 40186 | 1.4 |
| 03:25 ET | 3172 | 1.4 |
| 03:27 ET | 2650 | 1.4 |
| 03:30 ET | 6254 | 1.395 |
| 03:32 ET | 5632 | 1.4 |
| 03:34 ET | 1660 | 1.4 |
| 03:36 ET | 9455 | 1.39 |
| 03:38 ET | 2720 | 1.395 |
| 03:39 ET | 2851 | 1.395 |
| 03:41 ET | 44460 | 1.39 |
| 03:43 ET | 47799 | 1.4 |
| 03:45 ET | 7362 | 1.3912 |
| 03:48 ET | 6240 | 1.39 |
| 03:50 ET | 57638 | 1.395 |
| 03:52 ET | 22541 | 1.394 |
| 03:54 ET | 29787 | 1.39 |
| 03:56 ET | 94115 | 1.39 |
| 03:57 ET | 34588 | 1.39 |
| 03:59 ET | 99124 | 1.39 |
Today
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesOcugen Announces OCU400--Modifier Gene Therapy--Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024, from 11 hours ago by Dow Jones
11 hours ago by Dow Jones
Yesterday
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm, from 21 hours ago by Dow Jones
21 hours ago by Dow JonesDEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm, from 1:02PM ET on Sunday Apr 28, 2024 by Dow Jones
1:02PM ET on Sunday Apr 28, 2024 by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN, from 9:00AM ET on Sunday Apr 28, 2024 by Dow Jones
9:00AM ET on Sunday Apr 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocugen Inc | 329.4M | -5.3x | --- |
Q32 Bio Inc | 334.3M | -0.8x | --- |
Fibrobiologics Inc | 330.8M | -11.5x | --- |
Erasca Inc | 327.6M | -2.4x | --- |
XOMA Corp | 295.6M | -6.6x | --- |
ATAI Life Sciences NV | 320.4M | -6.9x | --- |
Company Information
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
Contact Information
- Headquarters
- 11 GREAT VALLEY PARKWAYMALVERN, PA, United States 19355
- Phone
- 484-328-4701
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Shankar Musunuri
- Principal Financial Officer, Interim Chief Accounting Officer
- Michael Breininger
- Chief Marketing Officer
- Huma Qamar
- Chief Scientific Officer, Executive Officer
- Arun Upadhyay
- Independent Director
- Kirsten Castillo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $329.4M |
|---|---|
Revenue (TTM) | $6.0M |
Shares Outstanding | 257.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.51 |
EPS | $-0.26 |
Book Value | $0.16 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 54.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,085.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
